In this issue:
Ustekinumab for UC
Herpes zoster with biological therapies in IBD
Tofacitinib and vedolizumab for UC
Patient parameters before IBD diagnosis
Intestinal complication predictors in Crohn’s disease
Low faecal calprotectin in UC
Malnutrition and micronutrient deficiencies in IBD
Excluded rectum outcomes in Crohn’s disease
Please login below to download this issue (PDF)